HGG-32. PNOC008: A PILOT TRIAL TESTING THE CLINICAL BENEFIT OF USING MOLECULAR PROFILING TO DETERMINE AN INDIVIDUALIZED TREATMENT PLAN IN CHILDREN AND YOUNG ADULTS WITH NEWLY DIAGNOSED HIGH-GRADE GLIOMA (EXCLUDING DIFFUSE INTRINSIC PONTINE GLIOMA)
Andrea Franson(Michigan Medicine), Sabine Mueller(University of California, San Francisco), Elizabeth George(University of California, San Francisco), Soniya Pinto(St. Jude Children's Research Hospital), Arastoo Vossough(Children's Hospital of Philadelphia), Angela J. Waanders(Lurie Children's Hospital), Adam Kraya(Translational Therapeutics (United States)), Roger J. Packer(Children's Hospital of Philadelphia), Annette M. Molinaro(University of California, San Francisco), Alyssa Reddy, Anu Banerjee(University of California, San Francisco), Erin Crotty(Seattle Children's Hospital), Mary Skrypek(Minnesota West Community & Technical College), John R. Crawford(University of California, Irvine), Lindsay Kilburn(Children's National), Schuyler Stoller(University of California, San Francisco), Sebastian M. Waszak(European Molecular Biology Laboratory), Eric H. Raabe(Johns Hopkins University), Nicholas Whipple(University of Utah), Tab Cooney(NGM Biopharmaceuticals (United States)), Janel Long-Boyle(University of California, San Francisco), Cassie Kline(Children's Hospital of Philadelphia), Priya Chan(Primary Children's Hospital), Jane E. Minturn(St Nicholas Hospital), David A. Solomon(University of California, San Francisco), Mohamed S Abdelbaki(Nationwide Children's Hospital), Jennifer Elster, Anne Bendel(Children's Minnesota), Michael Prados(University of California, San Francisco), Javad Nazarian(University Children's Hospital Zurich)
Cited by 2
Related Papers
The Long-term Natural History of the Weekly Symptomatic Status of Bipolar I Disorder
|Archives of General Psychiatry|2002|2.1k
A Prospective Investigation of the Natural History of the Long-term Weekly Symptomatic Status of Bipolar II Disorder
|Archives of General Psychiatry|2003|1.2k
Immune Checkpoint Inhibition for Hypermutant Glioblastoma Multiforme Resulting From Germline Biallelic Mismatch Repair Deficiency
|Journal of Clinical Oncology|2016|867
Functionally defined therapeutic targets in diffuse intrinsic pontine glioma
|Nature Medicine|2015|711